Femme et Homme
- | Pays :
- Sweden
- Australia
- Spain
- Les 12 autres...
- | Organes : -
- | Spécialités : -
Extrait
The purpose of this trial is to evaluate Repinotan HCl in patients with acute ischemic stroke. At study entry patients will be randomized to Repinotan HCl or placebo in a 1:1 ratio. The total treatment period wil be 72 hours.
Critère d'inclusion
- Stroke ,Acute ischemic stroke